Caption Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder associated with liver disease, ranging from fibrosis to hepatocellular carcinoma. The disease remains asymptomatic until its ...

Bank of America Securities analyst Alec Stranahan maintained a Buy rating on Krystal Biotech (KRYS – Research Report) yesterday and set a price ...

Krystal Biotech (KRYS) clinical data updates for both KB408 and KB407, the Company’s clinical-stage, inhaled genetic medicine ...

alpha-1 AT = alpha-1 antitrypsin; ANA = antinuclear antibodies; SMA = smooth muscle antibodies; anti-LKM1 = antibodies to liver/kidney microsome type 1; AMA = antimitochondrial antibodies ...

Liver diseases can be inherited (such as Wilson disease and alpha 1-antitrypsin deficiency) or acquired (for example hepatitis and liver cancer). Late-stage acute liver failure (ALF) has limited ...

Police have launched an investigation following the sudden death of a schoolgirl. Tilly Fern Wooler was rushed to hospital ...

Krystal Biotech's VYJUVEK, a groundbreaking gene therapy for DEB, achieved $83.8M in Q3 2024 sales. Read why I rate KRYS ...

The medicine hit its primary endpoint of a decrease in the average daily leg pain intensity as measured by the Numeric Pain ...

Rare genetic disorders affect approximately 1 in 10 people worldwide, meaning over 350 million individuals are living with these conditions. Despite their rarity, there are over 7,000 identified rare ...

Mereo Biopharma Group Plc (MREO) has received a new Buy rating, initiated by LifeSci Capital analyst, Cory Jubinville, PhD.Don't Miss Our ...